A-262
A-262 (Novichok agent)[edit]

A-262 is a chemical compound classified as a nerve agent and is part of the Novichok family of agents. These agents were developed in the Soviet Union during the late stages of the Cold War as part of a program to create more potent chemical weapons that could evade international detection and bans.
Chemical Properties[edit]
A-262, like other Novichok agents, is an organophosphate compound. It is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system functions.
Mechanism of Action[edit]
The primary mechanism of action for A-262 involves the irreversible binding to the active site of acetylcholinesterase. This binding prevents the breakdown of acetylcholine, resulting in prolonged neuromuscular transmission and cholinergic crisis. Symptoms of exposure can include muscle twitching, respiratory failure, convulsions, and potentially death.
Toxicity and Effects[edit]
A-262 is highly toxic, with effects similar to other nerve agents such as sarin and VX. Exposure can occur through inhalation, skin contact, or ingestion. The rapid onset of symptoms necessitates immediate medical intervention, typically involving the administration of atropine and pralidoxime to counteract the effects.
History and Development[edit]
The development of A-262 and other Novichok agents was part of a clandestine effort by the Soviet Union to create chemical weapons that could bypass existing arms control measures. The existence of these agents was not widely known until the 1990s, when former Soviet scientist Vil Mirzayanov revealed details about the program.
Detection and Decontamination[edit]
Detection of A-262 requires specialized equipment capable of identifying trace amounts of the compound. Decontamination procedures involve the use of reactive skin decontamination lotion (RSDL) and other chemical neutralizers to remove the agent from surfaces and skin.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian